Cargando…
Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent
The immunomodulatory properties of yeast β-1,3/1,6 glucans are mediated through their ability to be recognized by human innate immune cells. While several studies have investigated binding of opsonized and unopsonized particulate β-glucans to human immune cells mainly via complement receptor 3 (CR3)...
Autores principales: | Bose, Nandita, Chan, Anissa S. H., Guerrero, Faimola, Maristany, Carolyn M., Qiu, Xiaohong, Walsh, Richard M., Ertelt, Kathleen E., Jonas, Adria Bykowski, Gorden, Keith B., Dudney, Christine M., Wurst, Lindsay R., Danielson, Michael E., Elmasry, Natalie, Magee, Andrew S., Patchen, Myra L., Vasilakos, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740326/ https://www.ncbi.nlm.nih.gov/pubmed/23964276 http://dx.doi.org/10.3389/fimmu.2013.00230 |
Ejemplares similares
-
Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype
por: Chan, Anissa SH, et al.
Publicado: (2014) -
Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation
por: Chan, Anissa S. H., et al.
Publicado: (2016) -
Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse”
por: Goodridge, Helen S., et al.
Publicado: (2011) -
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer
por: Thomas, M., et al.
Publicado: (2017) -
Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies
por: Chan, Anissa S. H., et al.
Publicado: (2022)